Annual CAPEX
$2.55 M
+$1.36 M+115.09%
December 31, 2023
Summary
- As of February 7, 2025, IPHA annual capital expenditures is $2.55 million, with the most recent change of +$1.36 million (+115.09%) on December 31, 2023.
- During the last 3 years, IPHA annual CAPEX has fallen by -$10.34 million (-80.25%).
- IPHA annual CAPEX is now -96.52% below its all-time high of $73.22 million, reached on December 31, 2019.
Performance
IPHA CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
IPHA CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +115.1% | - | - |
| 3 y3 years | -80.3% | - | - |
| 5 y5 years | +50.8% | - | - |
IPHA CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +115.1% | ||||
| 5 y | 5-year | -96.5% | +115.1% | ||||
| alltime | all time | -96.5% | +1725.8% |
Innate Pharma SA CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $2.55 M(+115.1%) | - | - |
| Dec 2022 | $1.18 M(-24.8%) | - | - |
| Dec 2021 | $1.57 M(-87.8%) | - | - |
| Dec 2020 | $12.88 M(-82.4%) | - | - |
| Dec 2019 | $73.22 M(+4239.0%) | - | - |
| Dec 2018 | $1.69 M(-75.3%) | - | - |
| Dec 2017 | $6.82 M(-34.4%) | - | - |
| Dec 2016 | $10.40 M(+773.9%) | - | - |
| Dec 2015 | $1.19 M(-61.8%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2014 | $3.12 M(+441.8%) | - | - |
| Dec 2013 | $575.10 K(-63.5%) | - | - |
| Dec 2012 | $1.57 M(+250.8%) | - | - |
| Dec 2011 | $449.00 K(-17.0%) | - | - |
| Dec 2010 | $540.80 K(-24.1%) | - | - |
| Dec 2009 | $712.60 K(-74.5%) | - | - |
| Dec 2008 | $2.79 M(+57.1%) | - | - |
| Dec 2007 | $1.78 M(+88.0%) | - | - |
| Dec 2006 | $945.00 K(+577.9%) | - | - |
| Dec 2005 | $139.40 K | - | - |
FAQ
- What is Innate Pharma SA annual capital expenditures?
- What is the all time high annual CAPEX for Innate Pharma SA?
- What is Innate Pharma SA annual CAPEX year-on-year change?
What is Innate Pharma SA annual capital expenditures?
The current annual CAPEX of IPHA is $2.55 M
What is the all time high annual CAPEX for Innate Pharma SA?
Innate Pharma SA all-time high annual capital expenditures is $73.22 M
What is Innate Pharma SA annual CAPEX year-on-year change?
Over the past year, IPHA annual capital expenditures has changed by +$1.36 M (+115.09%)